Mediwound Ltd. current report, Q2 FY2020

MediWound Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by MediWound Ltd., a foreign private issuer, on May 20, 2020, for the month of May 2020. The filing serves to furnish corporate governance documents related to the upcoming Annual General Meeting of Shareholders scheduled for June 29, 2020.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing containing notices and proxy materials rather than a financial report.

Material Changes

No material financial changes or operational updates versus prior periods are disclosed in this filing. The content is limited to the announcement of shareholder meeting logistics.

Guidance, Outlook, and Risks

The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It solely incorporates by reference the Notice of Annual General Meeting and Proxy Statement (Exhibit 99.1) and the Proxy Card (Exhibit 99.2).

Key Facts for Investors to Verify

  • The Annual General Meeting of Shareholders is scheduled for June 29, 2020.
  • Shareholders should review the attached Notice and Proxy Statement (Exhibit 99.1) for specific agenda items and voting instructions.
  • The Proxy Card (Exhibit 99.2) is provided for shareholders to vote on matters related to the meeting.
  • Boaz Gur-Lavie, Chief Financial Officer, signed the report on behalf of the company.